| scholarly article | Q13442814 |
| P50 | author | Cecilia Morgantini | Q80166497 |
| P2093 | author name string | Srinivasa T Reddy | |
| Alan M Fogelman | |||
| Mohamad Navab | |||
| Satoshi Imaizumi | |||
| Victor Grijalva | |||
| P2860 | cites work | Preparation of lipid hydroperoxide-free low-density lipoproteins | Q77907804 |
| A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in | Q79381692 | ||
| Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics | Q28300402 | ||
| Lipid peroxidation in diabetes mellitus | Q34384380 | ||
| L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice | Q34566942 | ||
| Lipids and lipoproteins in patients with type 2 diabetes | Q35783120 | ||
| Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds | Q36296729 | ||
| Quantitative assessment of atherosclerotic lesions in mice | Q36456167 | ||
| Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis | Q36591939 | ||
| Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability | Q36725904 | ||
| The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice | Q37222394 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| ABCG1 mediated oxidized LDL-derived oxysterol efflux from macrophages | Q39778176 | ||
| Role of oxidized low density lipoprotein in atherogenesis | Q40343074 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. | Q41759686 | ||
| Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. | Q41759689 | ||
| Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. | Q41829964 | ||
| Binding characteristics of scavenger receptors on liver endothelial and Kupffer cells for modified low-density lipoproteins | Q42830218 | ||
| Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance | Q43541268 | ||
| Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol | Q43862770 | ||
| Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. | Q44480697 | ||
| Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats | Q44495010 | ||
| Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study | Q44745070 | ||
| Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis | Q44801373 | ||
| Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. | Q46030815 | ||
| Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice | Q46212386 | ||
| LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. | Q46430533 | ||
| D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice | Q46450296 | ||
| D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes | Q46531373 | ||
| Involvement of preexisting lipid hydroperoxides in Cu(2+)-stimulated oxidation of low-density lipoprotein. | Q54189438 | ||
| Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats | Q60684945 | ||
| Scavenger Receptor BI Mediates the Selective Uptake of Oxidized Cholesterol Esters by Rat Liver | Q63359539 | ||
| In VivoRegulation of Scavenger Receptor BI and the Selective Uptake of High Density Lipoprotein Cholesteryl Esters in Rat Liver Parenchymal and Kupffer Cells | Q63359542 | ||
| The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist | Q67584372 | ||
| Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins | Q70120377 | ||
| Oxidized lipids in atherogenesis: formation, destruction and action | Q73447357 | ||
| Imaging of aortic atherosclerotic lesions by (125)I-LDL, (125)I-oxidized-LDL, (125)I-HDL and (125)I-BSA | Q74083217 | ||
| Oxidative stress and coronary artery disease | Q77129618 | ||
| Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort | Q77764997 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| murine model | Q122890741 | ||
| P304 | page(s) | 3223-3228 | |
| P577 | publication date | 2010-09-08 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes | |
| P478 | volume | 59 |
| Q36709656 | A novel approach to oral apoA-I mimetic therapy |
| Q35742748 | Adverse effects of hyperlipidemia on bone regeneration and strength |
| Q35227165 | Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes |
| Q34238630 | Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review |
| Q47849940 | Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia |
| Q86194511 | Apolipoprotein A-I mimetic peptide reverse D-4F improves the biological functions of mouse bone marrow-derived late EPCs via PI3K/AKT/eNOS pathway |
| Q34594140 | Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents |
| Q35747768 | D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice |
| Q35217041 | D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway |
| Q38639717 | D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway |
| Q36763561 | Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins |
| Q34857041 | Effect of exposure to atmospheric ultrafine particles on production of free fatty acids and lipid metabolites in the mouse small intestine |
| Q35212906 | Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma |
| Q37838234 | HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms |
| Q30251918 | HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation |
| Q35904110 | HDL dysfunction in diabetes: causes and possible treatments |
| Q33680333 | HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. |
| Q85893004 | High density lipoprotein level is negatively associated with the increase of oxidized low density lipoprotein lipids after a fatty meal |
| Q38965138 | High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes. |
| Q38650575 | High-density lipoprotein mimetics: promises and challenges |
| Q34955938 | Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally |
| Q26821840 | New drugs for treating dyslipidemia: beyond statins |
| Q38835291 | Oxidized lipoprotein lipids and atherosclerosis |
| Q33956714 | Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study |
| Q36585836 | Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice |
| Q37469181 | Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts. |
| Q89012249 | The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications |
| Q38149803 | The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases |
| Q37596528 | The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis |
Search more.